دورية أكاديمية
Autoimmune hemolytic anemia associated with infliximab infusion in ulcerative colitis
العنوان: | Autoimmune hemolytic anemia associated with infliximab infusion in ulcerative colitis |
---|---|
المؤلفون: | Fazia A. Mir, Alhareth Al Juboori, Jack D. Bragg, Veysel Tahan |
المصدر: | İstanbul Kuzey Klinikleri, Vol 5, Iss 1, Pp 64-66 (2018) |
بيانات النشر: | KARE Publishing, 2018. |
سنة النشر: | 2018 |
المجموعة: | LCC:Medicine LCC:Medicine (General) |
مصطلحات موضوعية: | autoimmune hemolytic anemia, inflammatory bowel disease, infliximab, ulcerative colitis., Medicine, Medicine (General), R5-920 |
الوصف: | Infliximab is a monoclonal antibody that antagonizes the activity of tumor necrosis factor alpha to induce and maintain remission in patients with inflammatory bowel disease. Adverse effects associated with Infliximab infusions include infusion reactions, risk of infections, development of hematological malignancies, and pancytopenia. Autoimmune hemolytic anemia has rarely been reported in ulcerative colitis. Herein we report a case of drug-induced hemolytic anemia after infliximab infusion for treating ulcerative colitis. |
نوع الوثيقة: | article |
وصف الملف: | electronic resource |
اللغة: | English |
تدمد: | 2148-4902 |
Relation: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=nci&un=NCI-77045; https://doaj.org/toc/2148-4902 |
DOI: | 10.14744/nci.2017.77045 |
URL الوصول: | https://doaj.org/article/97297667e0194d67b3f7f8a44ad73d2b |
رقم الأكسشن: | edsdoj.97297667e0194d67b3f7f8a44ad73d2b |
قاعدة البيانات: | Directory of Open Access Journals |
كن أول من يترك تعليقا!